Lisa Butler
Lisa Butler
Verified email at adelaide.edu.au - Homepage
Title
Cited by
Cited by
Year
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
LM Butler, DB Agus, HI Scher, B Higgins, A Rose, C Cordon-Cardo, ...
Cancer research 60 (18), 5165-5170, 2000
7522000
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin
LM Butler, X Zhou, WS Xu, HI Scher, RA Rifkind, PA Marks, VM Richon
Proceedings of the National Academy of Sciences 99 (18), 11700-11705, 2002
6042002
Androgen receptor inhibits estrogen receptor-α activity and is prognostic in breast cancer
AA Peters, G Buchanan, C Ricciardelli, T Bianco-Miotto, MM Centenera, ...
Cancer research 69 (15), 6131-6140, 2009
3462009
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
HI Scher, G Buchanan, W Gerald, LM Butler, WD Tilley
Endocrine-related cancer 11 (3), 459-476, 2004
2702004
Dual roles of PARP-1 promote cancer growth and progression
MJ Schiewer, JF Goodwin, S Han, JC Brenner, MA Augello, JL Dean, ...
Cancer discovery 2 (12), 1134-1149, 2012
2442012
Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease
LA Selth, S Townley, JL Gillis, AM Ochnik, K Murti, RJ Macfarlane, KN Chi, ...
International Journal of Cancer 131 (3), 652-661, 2012
1972012
The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid
DC Coffey, MC Kutko, RD Glick, LM Butler, G Heller, RA Rifkind, PA Marks, ...
Cancer research 61 (9), 3591-3594, 2001
1832001
Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors
JL Dean, AK McClendon, TE Hickey, LM Butler, WD Tilley, AK Witkiewicz, ...
Cell cycle 11 (14), 2756-2761, 2012
1762012
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
LM Butler, Y Webb, DB Agus, B Higgins, TR Tolentino, MC Kutko, ...
Clinical cancer research 7 (4), 962-970, 2001
1582001
Minireview: the contribution of different androgen receptor domains to receptor dimerization and signaling
MM Centenera, JM Harris, WD Tilley, LM Butler
Molecular endocrinology 22 (11), 2373-2382, 2008
1552008
Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development
T Bianco-Miotto, K Chiam, G Buchanan, S Jindal, TK Day, M Thomas, ...
Cancer Epidemiology and Prevention Biomarkers 19 (10), 2611-2622, 2010
1312010
Maximizing the therapeutic potential of HSP90 inhibitors
LM Butler, R Ferraldeschi, HK Armstrong, MM Centenera, P Workman
Molecular cancer research 13 (11), 1445-1451, 2015
1222015
Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer
P Ravindranathan, TK Lee, L Yang, MM Centenera, L Butler, WD Tilley, ...
Nature communications 4 (1), 1-11, 2013
1192013
Circulating microRNAs predict biochemical recurrence in prostate cancer patients
LA Selth, SL Townley, AG Bert, PD Stricker, PD Sutherland, LG Horvath, ...
British journal of cancer 109 (3), 641-650, 2013
1142013
Control of Androgen Receptor Signaling in Prostate Cancer by the Cochaperone Small Glutamine–Rich Tetratricopeptide Repeat Containing Protein α
G Buchanan, C Ricciardelli, JM Harris, J Prescott, ZCL Yu, L Jia, ...
Cancer research 67 (20), 10087-10096, 2007
1032007
Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer …
DL Marrocco, WD Tilley, T Bianco-Miotto, A Evdokiou, HI Scher, ...
Molecular cancer therapeutics 6 (1), 51-60, 2007
1002007
Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer
SN Birrell, LM Butler, JM Harris, G Buchanan, WD Tilley
The FASEB Journal 21 (10), 2285-2293, 2007
992007
Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors
MM Centenera, JL Gillis, AR Hanson, S Jindal, RA Taylor, GP Risbridger, ...
Clinical Cancer Research 18 (13), 3562-3570, 2012
982012
Ex vivo culture of human prostate tissue and drug development
MM Centenera, GV Raj, KE Knudsen, WD Tilley, LM Butler
Nature reviews Urology 10 (8), 483-487, 2013
942013
Targeting cell cycle and hormone receptor pathways in cancer
CES Comstock, MA Augello, JF Goodwin, R De Leeuw, MJ Schiewer, ...
Oncogene 32 (48), 5481-5491, 2013
852013
The system can't perform the operation now. Try again later.
Articles 1–20